
Lorenzo Corsini
Co-Founder and Co-CEO
PhagoMed
Lorenzo is co-founder and co-CEO of PhagoMed, a biotech company developing targeted antimicrobials to treat microbiome-related conditions based on endolysins. From 2008 to 2017, he worked for the Boston Consulting Group. In his latest function as a Principal, he was advising pharmaceutical companies on topics ranging from corporate strategy to efficiency and quality in manufacturing, and leading large teams of consultants across multiple projects. Before, he did his PhD in molecular biology at EMBL Heidelberg. Lorenzo has diploma degrees in biochemistry and business administration.

Josh Hayes
US Regulatory Pathway for Phages as Veterinary Drugs
US FDA, Center for Veterinary Medicine

Christian Jäckel
Enzyme Product Developer
Chr. Hansen

Cathy Poor, PhD
Senior Scientist
Cargill